Journal
PSYCHIATRY RESEARCH
Volume 317, Issue -, Pages -Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.psychres.2022.114856
Keywords
Comorbid OCD-MDD; rTMS; Orbitofrontal cortex
Categories
Funding
- National Institute of Mental Health [K23MH116117, R01MH121089]
- Brain & Behavior Research Foundation [NARSAD-27111]
- Ryan Family
Ask authors/readers for more resources
This study examined the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) of the right orbi-tofrontal cortex (OFC) in patients with refractory obsessive-compulsive disorder (OCD) and comorbid Major Depressive Disorder. The results showed that the augmentation with OFC stimulation was well-tolerated and associated with further alleviation of symptoms in both OCD and depression, especially in individuals with more severe illnesses.
We examined the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) of the right orbi-tofrontal cortex (OFC) in patients with refractory obsessive-compulsive disorder (OCD) and comorbid Major Depressive Disorder. All participants (n = 26) received excitatory stimulation of the left dorsolateral prefrontal cortex followed by inhibitory stimulation of bilateral supplementary motor area for 10 sessions. In 18 patients with poor early OCD response, treatment was augmented with OFC inhibitory stimulation after the tenth treatment session. Augmentation with OFC stimulation was well-tolerated, and associated with further allevia-tion of both OCD and depression symptoms, particularly in individuals with more severe illnesses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available